 Human lymphotropic virus type II HTLV-II infection cohort New York intravenous drug users old infection risk factors human lymphotropic virus type II HTLV-II infection intravenous drug users IVDUs participants longitudinal study human immunodeficiency virus HIV infection New York methadone maintenance program participants HTLV-I/II seropositive HTLV-II-specific sequences polymerase chain reaction PCR HTLV-I- -II-specific sequences persons indeterminate serologic results PCR-positive HTLV-II HTLV-II infection age sex race socioeconomic status transfusion history HIV infection status Behavioral factors duration frequency intravenous drug use needle sharing visits galleries number sex partners HTLV-II infection findings contrast association risk factors HIV group IVDUs HTLV-II endemic infection HIV